These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11886395)

  • 1. True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity.
    Gallart T; Benito C; Reverter JC; Bosch F; Blay M; Tàssies D; Vigorito E; Cervera R; Font J; Gomis R; Campo E; Vives J
    Br J Haematol; 2002 Mar; 116(4):875-86. PubMed ID: 11886395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon.
    Rand JH; Wu XX; Andree HA; Ross JB; Rusinova E; Gascon-Lema MG; Calandri C; Harpel PC
    Blood; 1998 Sep; 92(5):1652-60. PubMed ID: 9716593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
    Arthritis Rheum; 2007 Dec; 57(8):1507-13. PubMed ID: 18050170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiphospholipid antibodies on procoagulant activity of activated platelets and platelet-derived microvesicles.
    Galli M; Bevers EM; Comfurius P; Barbui T; Zwaal RF
    Br J Haematol; 1993 Mar; 83(3):466-72. PubMed ID: 8485053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of three monoclonal IgM antiphospholipid antibodies recognizing different phospholipid antigens.
    Buschmann C; Fischer C; Ochsenhirt V; Neukirch C; Lackner KJ; von Landenberg P
    Ann N Y Acad Sci; 2005 Jun; 1051():240-54. PubMed ID: 16126965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are immunoglobulins with lupus anticoagulant activity specific for phospholipids?
    Pierangeli SS; Harris EN; Gharavi AE; Goldsmith G; Branch DW; Dean WL
    Br J Haematol; 1993 Sep; 85(1):124-32. PubMed ID: 8251379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
    Arnout J
    Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V; Banzato A; Bison E; Denas G; Padayattil Jose S; Ruffatti A
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
    López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
    Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assay principles of antiphospholipid antibodies and heterogeneity of the antibodies].
    Matsuura E
    Rinsho Byori; 2000 Apr; 48(4):317-22. PubMed ID: 10810876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS).
    Bidot CJ; Jy W; Horstman LL; Ahn ER; Yaniz M; Ahn YS
    Am J Hematol; 2006 Jun; 81(6):391-6. PubMed ID: 16680753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus anticoagulant activity of some antiphospholipid antibodies against phospholipid bound beta 2 glycoprotein I.
    Keeling DM; Wilson AJ; Mackie IJ; Isenberg DA; Machin SJ
    J Clin Pathol; 1993 Jul; 46(7):665-7. PubMed ID: 8157757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM; Jaskowski TD; Malmberg E; Lakos G; Branch DW; Tebo AE
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V gene analysis of anti-cardiolipin antibodies from (NZW x BXSB) F1 mice.
    Kita Y; Sumida T; Iwamoto I; Yoshida S; Koike T
    Immunology; 1994 Jul; 82(3):494-501. PubMed ID: 7959886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new variant of interaction between phospholipid antibodies and the protein C system.
    Bokarewa MI; Blombäck M; Egberg N; Rosén S
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):37-41. PubMed ID: 8180337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.